The use of routine laboratory biomarkers plays a key role in decision making in the clinical practice of COVID-19, allowing the development of clinical screening tools for personalized treatments. This study performed a short-term longitudinal cluster from patients with COVID-19 based on biochemical measurements for the first 72 h after hospitalization. Clinical and biochemical variables from 1039 confirmed COVID-19 patients framed on the “COVID Data Save Lives” were grouped in 24-h blocks to perform a longitudinal k-means clustering algorithm to the trajectories. The final solution of the three clusters showed a strong association with different clinical severity outcomes (OR for death: Cluster A reference, Cluster B 12.83 CI: 6.11–30.54, and Cluster C 14.29 CI: 6.66–34.43; OR for ventilation: Cluster-B 2.22 CI: 1.64–3.01, and Cluster-C 1.71 CI: 1.08–2.76), improving the AUC of the models in terms of age, sex, oxygen concentration, and the Charlson Comorbidities Index (0.810 vs. 0.871 with p < 0.001 and 0.749 vs. 0.807 with p < 0.001, respectively). Patient diagnoses and prognoses remarkably diverged between the three clusters obtained, evidencing that data-driven technologies devised for the screening, analysis, prediction, and tracking of patients play a key role in the application of individualized management of the COVID-19 pandemics.

Mol. Nutr. Food Res. 2018, 62, https://doi.org/10.1002/mnfr.201800619 DOI: https://doi.org/10.1002/mnfr.201800619 In 11 genetic‐diagnosed Huntington's disease patients with symptoms, one year of customized dietary intervention induced A) high diet adherence, which managed to curb unintentional weight loss in all participants; B) a significantly modified miRNA footprint of the disorder, leading the system to normalization; and C) general maintenance of neurological parameters. Further details can be found in article number https://doi.org/10.1002/mnfr.201800619 by Nieves González and co‐workers.